All news

Shared voting power spans 3.47M depositary shares at Bicycle Therapeutics (BCYC).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Armistice Capital, LLC and Steven Boyd have filed an amended beneficial ownership report for Bicycle Therapeutics plc (BCYC), disclosing a 6.85% stake. They beneficially own 3,472,000 American Depositary Shares, representing shared voting and dispositive power. The Master Fund, managed by Armistice Capital, directly holds these securities and is entitled to dividends and sale proceeds.

Read original source

BCYC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.